FDA clears Abbott's wireless point-of-care test

Abbott has received clearance from the FDA to begin marketing i-STAT 1 Wireless, a wireless version of the company's point-of-care testing system.

The wireless system will enable real-time transmission of diagnostic test results generated by i-STAT 1 directly from the patient bedside, the Princeton, N.J.-based pharmaceutical company stated. Sharing test results via a hospital's wireless network, caregivers will have more rapid access to information, Abbott added.

The i-STAT 1 Wireless handheld is certified for compatibility with existing wireless networks and is compatible with point-of-care data management systems used with earlier versions of the i-STAT System, Abbott said.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup